Navigating the complex landscape of pharmaceutical data is a daunting task, especially when dealing with a multitude of products in various development and post-market stages. This webinar introduces Megaputer’s AI-driven Insight-D™ solution, revolutionizing the insight discovery process. The solution integrates data from diverse sources, including communications with patients and doctors, advisory board meetings, clinical studies, and social media to facilitate the early detection of actionable insights.
Insight-D™ extracts key topics, monitors known issues (no matter what lingo was used to convey them), detects emerging trends and reveals sentiments associated with each discovered insight. Using AI techniques, each detected issue is supplemented by the corresponding context linking it with other issues.
The ultimate value of Insight-D™ lies in its ability to present the discovered insights in a simple interactive graphical dashboard allowing stakeholders from various departments to quickly identify insights most relevant to them.
Insight-D™ is an easy-to-use decision support system that streamlines the insight discovery process, saves time, and enables efficient and consistent decision-making. Join us to learn how this powerful tool can drive your company’s success. Watch the teaser below!
Introducing Insight-D™
About the Presenter
Sergei Ananyan
CEO of Megaputer
Sergei Ananyan is the CEO of Megaputer. Sergei heads a team of researchers and consultants creating and customizing text analysis products and solutions that address challenges encountered by practitioners in medical, pharmaceutical, financial, insurance, and manufacturing domains. He is a co-author of the chapter “The Role of Unstructured Data in Healthcare Analytics” in the book “Actionable Intelligence in Healthcare”.